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Porous silica particles grafted with various stimuli-responsive polymers are investigated 
with great interest for their use as smart pharmaceutical nanocarriers in advanced drug 
delivery systems (DDS). In particular, porous silica particles grafted with 
thermoresponsive polymers that exhibit thermally triggered on/off gating mechanisms have 
shown improved performance as hybrid DDS capable of controlling the release of different 
drugs in various mediums which resemble complex biological environments. In addition, 
the tuning of the drug release profiles as per requirements has proved possible with 
modifications to the porous core and the grafted thermoresponsive polymers. This 
highlight presents a brief discussion of basic preparation techniques and some recent 
significant developments in the field of thermoresponsive polymer grafted porous silica 
particles as smart pharmaceutical nanocarriers.  
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Porous silica particles are investigated with great interest as pharmaceutical nanocarriers in 
advanced drug delivery systems (DDS) [1–6]. In particular, organic groups and polymer-
grafted porous silica particles have shown better efficiency as DDS with respect to pristine 
particles. The efficiency and selective control over the drug release from porous 
nanocarriers can be further enhanced by grafting them with stimuli-responsive systems and 
smart polymers [7–9]. The grafting of smart polymers transforms simple porous particles 
into stimuli-controlled smart pharmaceutical nanocarriers. The stimuli-responsive polymer 
shell around the porous particles serves two purposes, first it helps to trigger the delivery of 
drug molecules by an external stimulus and second the polymer shell alters the surface 
properties of the bare particles preventing their aggregation. Porous silica particles 
exhibiting thermosensitive gating mechanisms are one of the most interesting and highly 
studied DDS [10]. Thermoresponsive polymers are a class of smart polymers and their 
physical properties are altered due to changes in temperature. These polymers exhibit a 
volume phase transition at their specific lower critical solution temperature (LCST). Above 
the LCST, the soluble hydrated polymer chains collapse to form insoluble hydrophobic 
globules, this phenomenon is called as the coil-to-globule transition and is reversible [11–
13]. Examples of the most common thermoresponsive polymers are 
poly(Nisopropylacrylamide) (PNIPAM) and its various copolymers such as poly(N-
isopropylacrylamide-co-acrylamide) (poly(NIPAM-co-AA)), poly(N-isopropylacrylamide-
co-acrylic acid) etc., poly(N-vinyl caprolactam), poly(N-ethyl oxazoline), and poly(methyl 
vinyl ether)s etc. (refer to Fig. 1a for structures of some common thermoresponsive 
polymers). The grafting of thermosensitive polymers applies a pore-opening (on) pore-
closing (off) mechanism to the porous particles by virtue of their transition at the LCST. 
The polymers in their extended coil conformation at below the LCST occupy most of the 
pore volume which prevents the diffusion of molecules loaded inside them. Instead, above 
the LCST the polymer chains collapse to form very compact hydrophobic globules that 
open the pores. This mechanism is controlled by changes in temperature (external stimulus, 
Fig. 1b). The thermosensitive gating mechanism allows triggering the drug release at 
elevated temperatures (above LCST) and at desired rates. The gating mechanism can also 
be reversed by adjusting the pore diameters or molecular weight and LCST/upper critical 
solution temperature (UCST) of the polymers. Post-synthesis surface grafting of 
thermoresponsive polymers by ‘graft from’ or ‘graft to’ methods on porous particles is 
carried out to prepare thermosensitive DDS. The well known alkoxysilane grafting 
protocol is used for the grafting of monomers, initiators, or directly preformed 
thermoresponsive polymers on porous silica particles [14]. Due to the inert nature of silica 
it does not interfere with the various surface initiated polymerization (SIP) techniques such 
as free radical polymerization or atom transfer radical polymerization (ATRP), reversible 
addition–fragmentation chain transfer (RAFT) etc. [15–17]. Apart from applying the gating 
mechanism, the polymer additionally helps in the internalization of particles (endocytosis) 
in cells by undergoing the thermoresponsive transition. The transition of the polymer at its 
LCST transforms the hydrophilic surface of the particles into a hydrophobic surface (Fig. 
1c). As the hybrid particles at that temperature exhibit a hydrophobic surface they can be 
easily internalized by various cells. Almost a 20-fold increase in cellular uptake was 
observed at elevated (above LCST) temperatures [18–20]. In addition to the alteration of 
surface properties the coil-to-globule transition of thermoresponsive polymers can be used 
to hide and reveal or mask and uncover active functionalities present (or purposely grafted) 




Some recent reports in the literature present significant developments in the preparation of 
thermoresponsive smart nanocarriers based on porous silica particles for the delivery of 
drugs from various classes such as anti-cancer, anti-inflammatory, antioxidants, and 
proteins. These developments also include the synthesis of new multi-responsive 
copolymers, which generates complex double or triple responsive advanced smart 
nanocarriers. Yu et al. [21] recently reported a porous silica-based DDS grafted with a 
temperature and reactive oxygen species (ROS) responsive polymer (ROSP@mesoporous 
silica nanoparticles, MSNs) for delivery of the anticancer drug doxorubicin (DOX). The 
thermo andROSresponsive 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acrylate 
modified polymer was grafted on porous silica particles and controls the release of the 
drug. Hydrogen peroxide mediated detachment of the ROS species 4-(methylol) 
phenylboronic acid pinacol ester at elevated temperatures from the copolymer structure 
(Fig. 2) generates the poly(NIPAM-co-AA) copolymer which has a LCST at around 37°C. 
The transition of the polymer at that temperature helps in releasing DOX by opening the 
pores. The hybrid particles showed good biocompatibility and internalization by cells. 
With the increased concentration ofDOXdue to its release with time the Hela cell viability 
was decreased to less than 30 %. Hegazy et al. [22] reported magnetic, reductive, and 
thermo triple-responsive nanocarriers based on magnetite–silica (core) thermo/pH 
responsive polymer (shell) nanoparticles. This is a classic example of how multiple 
responsive mechanisms can be grafted on porous silica particles. The loading and release 
of DOX mediated by all three stimuli mechanisms was reported where a significant 
difference in DOX release at low and elevated temperatures was observed. In comparison 
with the single responsive systems, such triple-responsive porous smart pharmaceutical 
carriers hold greater potential for controlling the drug delivery process in the complicated 
blood circulation and pathological environment. Although the work does not present any 
biological testing, it shows the stability of the hybrid magnetic thermoresponsive polymer 
grafted porous silica nanoparticles in physiological conditions (saline buffer). This is 
important to prove that the silica-based hybrid porous materials can remain intact during 
their use. Wu et al. [23] reported a dual (pH/thermo) responsive DDS based on porous 
silica with a mixed polymer shell of PNIPAM and polyethylene glycol (PEG). The 
transition of PNIPAM chains above its LCST showed thermally triggered release of DOX 
from the porous particles at elevated temperatures while the PEG chains were found to 
provide a hydrophilic barrier and impart colloidal stability and in vivo longevity to the 
DDS. A very good internalization of the thermoresponsive polymergrafted particles by 
HCT-116 cells was observed by incubation for 12 h at pH 7.4. The cell cytotoxicity 
experiments using the drug (DOX)-loaded particles showed decreased cell viability (up to 
40 %). Some other recent reports on thermoresponsive silica include the development of 
porous silica–PNIPAM or its copolymer-based hybrid DDS for the delivery of anti-
inflammatory drugs such as ibuprofen [24–26], antioxidants like rutin [27] and quercetin 
[28], and fluorescent molecules like fluorescein [29]. Most of these works point out the 
important roles of pore dimensions (volume/multimodality), PNIPAM-based copolymer 
composition, and molecular weight of the polymers in modulating the drug release profiles 
from the thermoresponsive silica particles. Importantly, these studies prove that desired 
control over the drug release in different environments is possible by selective 
modifications of the hybrid DDS. Theoretically, no or very low drug release by the 
thermoresponsive polymer-grafted particles is expected below the LCST of the polymer. 
Instead, a triggered higher release of drugs at elevated temperatures above the LCST is 
expected. However, this trend can be reversed. In the work by Guisasola et al. [29] the 
synthesis and testing of magnetic porous silica grafted with thermoresponsive polymeric 
gates with opposite controlled release behaviours was presented. They proved that the 
thermally triggered release profiles of fluorescein from the thermoresponsive copolymer 
based on NIPAM and N-hydroxymethyl acrylamide (NHMA) grafted porous particles 
depend upon the presence of cross-linked and not cross-linked (linear chains or brushes) 
polymers. A low release profile below the LCST (42°C) of the polymer was observed for 
the cross-linked polymer-grafted particles. Instead, the release profile was reversed for the 
linear polymer-grafted particles which showed higher drug release below the LCST. In 
another recent report [27], it is proved that, not only the polymer shell but also the 
multimodal porous channel structure present on the porous silica particles can alter the 
drug release behaviour from porous silica-based thermoresponsive DDS. Such reversible 
thermoresponsive release behaviour can be of great use in therapies where a sustained 
release of drug is desired at higher temperatures instead of a triggered higher release. A 
recent study by Yu et al. [30] reported the loading and thermally triggered release of 
bovine hemoglobin (BHb) protein from thermoreponsive porous silica particles. Proteins 
are big biomolecules and may not be incorporated inside the pores on conventional MCM-
41 or SBA-15 type porous silica nano or microparticles. For this purpose novel pore-
expanded mesoporous silica nanoparticles (MSNs) with pore sizes of 11 nm were 
synthesised and grafted with thermoresponsive PNIPAM. PEGylation of the interior pore 
surface was done to avoid silica surface–protein interactions. A thermally triggered BHb 
release in physiological conditions was observed with significant difference in protein 
release below (25°C) and above (37°C) the LCST of the polymer (Fig. 3). This is a rare 
report where loading and release of protein from thermoresponsive porous silica was 
tested. The pore expansion in porous silica is possible due to various recently invented 
synthetic techniques which give the possibility of tuning the pore diameters [31]. The pore 
diameters and volumes can be increased to incorporate large molecules such as proteins. 
Related to this, a previous study by Tu et al. [32] showed the importance of tuning of the 
diameters of the pores on silica for the incorporation of big molecules like proteins. They 
investigated the encapsulation and release behaviour for seven model proteins named 
alactalbumin (LAC), ovalbumin (OVA), bovine serum albumin (BSA), catalase (CAT), 
haemoglobin (HB), lysozyme (LYS), and cytochrome (CYT) from large pore porous silica 
particles functionalized with 3-aminopropyltriethoxysilane or 3-[2-(2- 
aminoethylamino)ethylamino]propyltrimethoxysilane (APMSNs and AEP-MSNs) (Fig. 3). 
The report by Yu et al. proved that further control over the release of proteins from 
expanded pore silica can be achieved by grafting with thermoresponsive polymers, and 
protein–silica surface interactions can be limited by grafting the pore walls with PEG 
chains. 
 
Conclusions and Future Challenges 
Due to very intense research in the last two decades on bare or simply functionalized 
porous silica particle based DDS, they have reached the advanced stages of testing such as 
clinical trials. Many aspects such as in vitro and in vivo drug release studies, 
biocompatibility, toxicity, biocompatibility, internalization by cells, and fate in vivo have 
been studied in detail [33]. Instead, the polymer or in particular the stimuli responsive 
polymer-grafted porous silica based DDS still have to go a long way before they reach the 
final stages of testing. Hence there is great scope for continued research for the 
improvement of thermoresponsive polymer-grafted porous silica nanocarriers. The future 
research on these materials will continue in the following main directions: 1) To design 
and synthesise an ideal DDS with a perfect thermosensitive gating mechanism where 
ideally complete blockage of drugs is possible below the LCST of the polymer. Although 
several new and more efficient thermoresponsive polymers and copolymers have been 
synthesized and tested to improve the performance of thermoresponsive nanocarriers, the 
approval of these new polymers for biomedical uses is a matter for separate discussion. 2) 
Extended detailed studies about the biocompatibility, toxicity, and internalization. Studies 
on the fate of the hybrid nanocarriers in vivo after drug release, that is either in vivo 
degradation of them or clearance from the body. There are no conclusive studies on this 
point reported to date. 3) In the case that porous thermoresponsive silicas will cross all the 
hurdles and come up as efficient DDS, reproducible and large scale synthesis methods for 
their production will be a challenge. The synthesis methods should be developed in such a 
way that they will guarantee the production of polymer-grafted porous silicas with desired 
properties for biomedical use. Considering the recent continued interest and advancements, 
thermoresponsive polymer-grafted porous silica materials have shown great potential for 
being the next generation smart pharmaceutical nanocarriers. The challenges related to 
further development of these materials are wide open and continued research in future will 
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Fig. 1 A) Structures of some common thermoresponsive polymers B) Themoresponsive 
polymer PNIPAM grafted porous silica showing thermosensitive pore-opening pore-
closing mechanism C) Surface property change mediated internalization of 









Fig. 2 Thermo and ROS responsive porous silica particles and drug (DOX) release profile 
from poly (NIPAM-co-AA) generated particles. Reproduced with permission from 












Fig. 3 (a) Encapsulation efficiency (EE%) of seven proteins in MSNs (black bars), AP-
MSNs (red bars), and AEP-MSNs (blue bars); (b) Zeta potential of MSNs, AP-MSNs, and 
AEP-MSNs in 1 mM PB, pH 7.4. (c) EE% of seven proteins (d) Corresponding loading 
capacity (mg/g) for all proteins. Reproduced with permission from reference 32. Copyright 
ACS 2016. 
 
 
 
 
 
